Vyepti Special Precautions

Traceability: In order to improve the traceability of biological medicinal products, the name and the batch number of the administered medicinal product should be clearly recorded.
Serious hypersensitivity: Serious hypersensitivity reactions, including anaphylaxis reactions has been reported and may develop within minutes of the infusion. Serious hypersensitivity reactions may occur. If a serious hypersensitivity reaction occurs, administration of Vyepti should be discontinued immediately and appropriate therapy initiated.
Use in Pregnancy: Limited data. Vyepti should not be used by pregnant women, unless the potential benefit justifies the potential risk to the foetus.
Use in Lactation: No data is available. The developmental and health benefits of breastfeeding should be considered, as well as the mother's clinical need for Vyepti and any potential effects on the breastfed infant.